Could a common antidepressant ease the exhaustion of dialysis?
NCT ID NCT06609343
Summary
This study is testing if bupropion, a medication used for depression and smoking cessation, can help reduce the severe fatigue experienced by people on kidney dialysis. Sixteen participants will take the pill three times a week during their dialysis sessions for eight weeks. Researchers will measure changes in their fatigue levels, quality of life, and certain blood markers to see if the treatment is helpful and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Dialysis Medical Center (DMC)
San Antonio, Texas, 78229, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.